Complications of pelvic lymph node dissection for prostate cancer.
Identifieur interne : 004F87 ( Main/Exploration ); précédent : 004F86; suivant : 004F88Complications of pelvic lymph node dissection for prostate cancer.
Auteurs : K A Keegan [États-Unis] ; M S CooksonSource :
- Current urology reports [ 1534-6285 ] ; 2011.
Descripteurs français
- KwdFr :
- Analyse de survie, Complications postopératoires (physiopathologie), Complications postopératoires (épidémiologie), Dissection (effets indésirables), Embolie pulmonaire (physiopathologie), Embolie pulmonaire (étiologie), Humains, Incidence, Invasion tumorale (anatomopathologie), Lymphadénectomie (), Lymphadénectomie (effets indésirables), Lymphocèle (physiopathologie), Lymphocèle (étiologie), Lymphoedème (physiopathologie), Lymphoedème (étiologie), Lésions du système vasculaire (physiopathologie), Lésions du système vasculaire (étiologie), Mâle, Noeuds lymphatiques (), Noeuds lymphatiques (anatomopathologie), Pelvis (), Pelvis (anatomopathologie), Pronostic, Stade de la tumeur, Thrombose veineuse (physiopathologie), Thrombose veineuse (étiologie), Tumeurs de la prostate (), Tumeurs de la prostate (anatomopathologie), Tumeurs de la prostate (mortalité), Évaluation des risques.
- MESH :
- anatomopathologie : Invasion tumorale, Noeuds lymphatiques, Pelvis, Tumeurs de la prostate.
- effets indésirables : Dissection, Lymphadénectomie.
- mortalité : Tumeurs de la prostate.
- physiopathologie : Complications postopératoires, Embolie pulmonaire, Lymphocèle, Lymphoedème, Lésions du système vasculaire, Thrombose veineuse.
- épidémiologie : Complications postopératoires.
- étiologie : Embolie pulmonaire, Lymphocèle, Lymphoedème, Lésions du système vasculaire, Thrombose veineuse.
- Analyse de survie, Humains, Incidence, Lymphadénectomie, Mâle, Noeuds lymphatiques, Pelvis, Pronostic, Stade de la tumeur, Tumeurs de la prostate, Évaluation des risques.
English descriptors
- KwdEn :
- Dissection (adverse effects), Humans, Incidence, Lymph Node Excision (adverse effects), Lymph Node Excision (methods), Lymph Nodes (pathology), Lymph Nodes (surgery), Lymphedema (etiology), Lymphedema (physiopathology), Lymphocele (etiology), Lymphocele (physiopathology), Male, Neoplasm Invasiveness (pathology), Neoplasm Staging, Pelvis (pathology), Pelvis (surgery), Postoperative Complications (epidemiology), Postoperative Complications (physiopathology), Prognosis, Prostatic Neoplasms (mortality), Prostatic Neoplasms (pathology), Prostatic Neoplasms (surgery), Pulmonary Embolism (etiology), Pulmonary Embolism (physiopathology), Risk Assessment, Survival Analysis, Vascular System Injuries (etiology), Vascular System Injuries (physiopathology), Venous Thrombosis (etiology), Venous Thrombosis (physiopathology).
- MESH :
- adverse effects : Dissection, Lymph Node Excision.
- epidemiology : Postoperative Complications.
- etiology : Lymphedema, Lymphocele, Pulmonary Embolism, Vascular System Injuries, Venous Thrombosis.
- methods : Lymph Node Excision.
- mortality : Prostatic Neoplasms.
- pathology : Lymph Nodes, Neoplasm Invasiveness, Pelvis, Prostatic Neoplasms.
- physiopathology : Lymphedema, Lymphocele, Postoperative Complications, Pulmonary Embolism, Vascular System Injuries, Venous Thrombosis.
- surgery : Lymph Nodes, Pelvis, Prostatic Neoplasms.
- Humans, Incidence, Male, Neoplasm Staging, Prognosis, Risk Assessment, Survival Analysis.
Abstract
Pelvic lymph node dissection (PLND) represents the standard for detection of occult pelvic nodal metastases from prostate cancer, and may be performed separately from or at the time of radical prostatectomy. In addition to its potential for diagnostic staging, a PLND may be therapeutic in some patients. However, considerable debate centers on the appropriate candidates for the procedure, the extent and proper boundaries of dissection, optimal surgical approach, and absolute oncologic benefit. Several series suggest that there likely is limited benefit of PLND in low-risk patients and that PLND can be safely omitted in a high percentage of men undergoing contemporary radical prostatectomy. Furthermore, the value of PLND in patients with intermediate- and high-risk disease must be balanced against the potential morbidity of the procedure. In the setting of this debate, concern over morbidity directly attributable to this procedure is of paramount importance. This review focuses on the complications associated with PLND, including lymphocele, thromboembolic events, ureteral injury, nerve injury, vascular injury, and lymphedema.
DOI: 10.1007/s11934-011-0179-z
PubMed: 21394597
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002717
- to stream PubMed, to step Curation: 002717
- to stream PubMed, to step Checkpoint: 002717
- to stream Ncbi, to step Merge: 004191
- to stream Ncbi, to step Curation: 004191
- to stream Ncbi, to step Checkpoint: 004191
- to stream Main, to step Merge: 005024
- to stream Main, to step Curation: 004F87
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Complications of pelvic lymph node dissection for prostate cancer.</title>
<author><name sortKey="Keegan, K A" sort="Keegan, K A" uniqKey="Keegan K" first="K A" last="Keegan">K A Keegan</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Urologic Surgery, Vanderbilt University Medical Center, A-1302 Medical Center North, Nashville, TN 37232, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Urologic Surgery, Vanderbilt University Medical Center, A-1302 Medical Center North, Nashville, TN 37232</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Cookson, M S" sort="Cookson, M S" uniqKey="Cookson M" first="M S" last="Cookson">M S Cookson</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:21394597</idno>
<idno type="pmid">21394597</idno>
<idno type="doi">10.1007/s11934-011-0179-z</idno>
<idno type="wicri:Area/PubMed/Corpus">002717</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002717</idno>
<idno type="wicri:Area/PubMed/Curation">002717</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002717</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002717</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002717</idno>
<idno type="wicri:Area/Ncbi/Merge">004191</idno>
<idno type="wicri:Area/Ncbi/Curation">004191</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004191</idno>
<idno type="wicri:Area/Main/Merge">005024</idno>
<idno type="wicri:Area/Main/Curation">004F87</idno>
<idno type="wicri:Area/Main/Exploration">004F87</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Complications of pelvic lymph node dissection for prostate cancer.</title>
<author><name sortKey="Keegan, K A" sort="Keegan, K A" uniqKey="Keegan K" first="K A" last="Keegan">K A Keegan</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Urologic Surgery, Vanderbilt University Medical Center, A-1302 Medical Center North, Nashville, TN 37232, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Urologic Surgery, Vanderbilt University Medical Center, A-1302 Medical Center North, Nashville, TN 37232</wicri:regionArea>
<placeName><region type="state">Tennessee</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Cookson, M S" sort="Cookson, M S" uniqKey="Cookson M" first="M S" last="Cookson">M S Cookson</name>
</author>
</analytic>
<series><title level="j">Current urology reports</title>
<idno type="eISSN">1534-6285</idno>
<imprint><date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Dissection (adverse effects)</term>
<term>Humans</term>
<term>Incidence</term>
<term>Lymph Node Excision (adverse effects)</term>
<term>Lymph Node Excision (methods)</term>
<term>Lymph Nodes (pathology)</term>
<term>Lymph Nodes (surgery)</term>
<term>Lymphedema (etiology)</term>
<term>Lymphedema (physiopathology)</term>
<term>Lymphocele (etiology)</term>
<term>Lymphocele (physiopathology)</term>
<term>Male</term>
<term>Neoplasm Invasiveness (pathology)</term>
<term>Neoplasm Staging</term>
<term>Pelvis (pathology)</term>
<term>Pelvis (surgery)</term>
<term>Postoperative Complications (epidemiology)</term>
<term>Postoperative Complications (physiopathology)</term>
<term>Prognosis</term>
<term>Prostatic Neoplasms (mortality)</term>
<term>Prostatic Neoplasms (pathology)</term>
<term>Prostatic Neoplasms (surgery)</term>
<term>Pulmonary Embolism (etiology)</term>
<term>Pulmonary Embolism (physiopathology)</term>
<term>Risk Assessment</term>
<term>Survival Analysis</term>
<term>Vascular System Injuries (etiology)</term>
<term>Vascular System Injuries (physiopathology)</term>
<term>Venous Thrombosis (etiology)</term>
<term>Venous Thrombosis (physiopathology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Analyse de survie</term>
<term>Complications postopératoires (physiopathologie)</term>
<term>Complications postopératoires (épidémiologie)</term>
<term>Dissection (effets indésirables)</term>
<term>Embolie pulmonaire (physiopathologie)</term>
<term>Embolie pulmonaire (étiologie)</term>
<term>Humains</term>
<term>Incidence</term>
<term>Invasion tumorale (anatomopathologie)</term>
<term>Lymphadénectomie ()</term>
<term>Lymphadénectomie (effets indésirables)</term>
<term>Lymphocèle (physiopathologie)</term>
<term>Lymphocèle (étiologie)</term>
<term>Lymphoedème (physiopathologie)</term>
<term>Lymphoedème (étiologie)</term>
<term>Lésions du système vasculaire (physiopathologie)</term>
<term>Lésions du système vasculaire (étiologie)</term>
<term>Mâle</term>
<term>Noeuds lymphatiques ()</term>
<term>Noeuds lymphatiques (anatomopathologie)</term>
<term>Pelvis ()</term>
<term>Pelvis (anatomopathologie)</term>
<term>Pronostic</term>
<term>Stade de la tumeur</term>
<term>Thrombose veineuse (physiopathologie)</term>
<term>Thrombose veineuse (étiologie)</term>
<term>Tumeurs de la prostate ()</term>
<term>Tumeurs de la prostate (anatomopathologie)</term>
<term>Tumeurs de la prostate (mortalité)</term>
<term>Évaluation des risques</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Dissection</term>
<term>Lymph Node Excision</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Invasion tumorale</term>
<term>Noeuds lymphatiques</term>
<term>Pelvis</term>
<term>Tumeurs de la prostate</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Dissection</term>
<term>Lymphadénectomie</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Postoperative Complications</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term>
<term>Lymphocele</term>
<term>Pulmonary Embolism</term>
<term>Vascular System Injuries</term>
<term>Venous Thrombosis</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Lymph Node Excision</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Prostatic Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Tumeurs de la prostate</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Lymph Nodes</term>
<term>Neoplasm Invasiveness</term>
<term>Pelvis</term>
<term>Prostatic Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Complications postopératoires</term>
<term>Embolie pulmonaire</term>
<term>Lymphocèle</term>
<term>Lymphoedème</term>
<term>Lésions du système vasculaire</term>
<term>Thrombose veineuse</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Lymphedema</term>
<term>Lymphocele</term>
<term>Postoperative Complications</term>
<term>Pulmonary Embolism</term>
<term>Vascular System Injuries</term>
<term>Venous Thrombosis</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Lymph Nodes</term>
<term>Pelvis</term>
<term>Prostatic Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Complications postopératoires</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Embolie pulmonaire</term>
<term>Lymphocèle</term>
<term>Lymphoedème</term>
<term>Lésions du système vasculaire</term>
<term>Thrombose veineuse</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Incidence</term>
<term>Male</term>
<term>Neoplasm Staging</term>
<term>Prognosis</term>
<term>Risk Assessment</term>
<term>Survival Analysis</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Analyse de survie</term>
<term>Humains</term>
<term>Incidence</term>
<term>Lymphadénectomie</term>
<term>Mâle</term>
<term>Noeuds lymphatiques</term>
<term>Pelvis</term>
<term>Pronostic</term>
<term>Stade de la tumeur</term>
<term>Tumeurs de la prostate</term>
<term>Évaluation des risques</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Pelvic lymph node dissection (PLND) represents the standard for detection of occult pelvic nodal metastases from prostate cancer, and may be performed separately from or at the time of radical prostatectomy. In addition to its potential for diagnostic staging, a PLND may be therapeutic in some patients. However, considerable debate centers on the appropriate candidates for the procedure, the extent and proper boundaries of dissection, optimal surgical approach, and absolute oncologic benefit. Several series suggest that there likely is limited benefit of PLND in low-risk patients and that PLND can be safely omitted in a high percentage of men undergoing contemporary radical prostatectomy. Furthermore, the value of PLND in patients with intermediate- and high-risk disease must be balanced against the potential morbidity of the procedure. In the setting of this debate, concern over morbidity directly attributable to this procedure is of paramount importance. This review focuses on the complications associated with PLND, including lymphocele, thromboembolic events, ureteral injury, nerve injury, vascular injury, and lymphedema.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Tennessee</li>
</region>
</list>
<tree><noCountry><name sortKey="Cookson, M S" sort="Cookson, M S" uniqKey="Cookson M" first="M S" last="Cookson">M S Cookson</name>
</noCountry>
<country name="États-Unis"><region name="Tennessee"><name sortKey="Keegan, K A" sort="Keegan, K A" uniqKey="Keegan K" first="K A" last="Keegan">K A Keegan</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004F87 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004F87 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:21394597 |texte= Complications of pelvic lymph node dissection for prostate cancer. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:21394597" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |